Chimeric fab fragments of antibodies to recombinant Ebola virus glycoprotein


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Previously, we have determined the nucleotide and amino acid sequences of the variable domains of three mouse monoclonal antibodies specific to the individual epitopes of the Ebola virus glycoprotein: GPE118 (IgG), GPE325 (IgM) and GPE534 (IgG) [1]. In the present paper, chimeric Fab fragments of Fab118, Fab325, and Fab534 antibodies were obtained based on the variable domains of murine antibodies by attaching CH1 and CL constant regions of human kappa-IgG1 to them. The recombinant chimeric Fab fragments were synthesized in the heterologous expression system Escherichia coli, isolated and purified using metal chelate affinity chromatography. The immunochemical properties of the obtained Fab fragments were studied by immunoblotting techniques as well as indirect and competitive ELISA using recombinant Ebola virus proteins: EBOV rGPdTM (recombinant glycoprotein of Ebola hemorrhagic fever virus without the transmembrane domain), NP (nucleoprotein) and VP40 (structural protein). The identity of recombinant chimeric Fab fragments, as well as their specificity to the recombinant glycoprotein of Ebola hemorrhagic fever virus (EBOV GP) was proved. The results of indirect ELISA evidence the absence of immunological cross-reactivity to NP and VP40 proteins of Ebola virus. The dissociation constants of the antigen-antibody complex Kd equal to 5.0, 1.0 and 1.0 nM for Fab118, Fab325 and Fab534, respectively, were determined; they indicate high affinity of the obtained experimental samples to EBOV GP. The epitope specificity of Fab fragments was studied using a panel of commercial neutralizing antibodies. It was found that all studied antibodies to EBOV GP are targeted to different epitopes, while the epitopes of the recombinant chimeric Fab fragments and original murine monoclonal antibodies (mAbs) coincide. All the obtained and studied mAbs to EBOV GP are specific to epitopes that coincide or overlap the epitopes of three commercial neutralizing mAbs to Ebola virus: epitopes Fab118 and Fab325 overlap the epitope of the known commercial mAb h13F6; Fab325 epitope also overlaps mAb c6D8 epitope; Fab534 epitope is located near mAb KZ52 conformational epitope, in the formation of which amino acid residues of GP1 and GP2 domains of EBOV GP are involved.

About the authors

A. A. Panina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Author for correspondence.
Email: paniann07@yandex.ru
Russian Federation, Moscow, 117997

I. G. Dement’yeva

Russian Research Center for Molecular Diagnostics and Therapy

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117149

T. K. Aliev

Department of Chemistry

Email: paniann07@yandex.ru
Russian Federation, Moscow, 119991

V. A. Toporova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117997

M. N. Bokov

Russian Research Center for Molecular Diagnostics and Therapy

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117149

L. P. Pozdnyakova

Russian Research Center for Molecular Diagnostics and Therapy

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117149

O. B. Shemchukova

Russian Research Center for Molecular Diagnostics and Therapy

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117149

D. A. Dolgikh

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117997

P. G. Sveshnikov

Russian Research Center for Molecular Diagnostics and Therapy

Email: paniann07@yandex.ru
Russian Federation, Moscow, 117149

M. P. Kirpichnikov

Department of Biology

Email: paniann07@yandex.ru
Russian Federation, Moscow, 119991

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Ltd.